Cargando…

Remission in psoriatic arthritis: is it possible and how can it be predicted?

INTRODUCTION: Since remission is now possible in psoriatic arthritis (PsA) we wished to examine remission rates in PsA patients following anti tumour necrosis factor alpha (TNFα) therapy and to examine possible predictors of response. METHODS: Analysis of a prospective patient cohort attending a bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saber, Tajvur P, Ng, CT, Renard, Guillaume, Lynch, Bernadette M, Pontifex, Eliza, Walsh, Ceara AE, Grier, Alexia, Molloy, Marian, Bresnihan, Barry, FitzGerald, Oliver, Fearon, Ursula, Veale, Douglas J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911878/ https://www.ncbi.nlm.nih.gov/pubmed/20482783 http://dx.doi.org/10.1186/ar3021

Ejemplares similares

Differential Expression of NK Receptors CD94 and NKG2A by T Cells in Rheumatoid Arthritis Patients in Remission Compared to Active Disease
por: Walsh, Ceara E., et al.
Publicado: (2011)

Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy - a single centre, open-label study
por: Pontifex, Eliza K, et al.
Publicado: (2011)

Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study
por: Gibbs, A, et al.
Publicado: (2005)

Long-term remission and biologic persistence rates: 12-year real-world data
por: Murray, Kieran, et al.
Publicado: (2021)

What makes psoriatic and rheumatoid arthritis so different?
por: Veale, Douglas James, et al.
Publicado: (2015)

Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss
por: Fearon, U, et al.
Publicado: (2005)

The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005)

Toll-Like Receptor 2 Induced Angiogenesis and Invasion Is Mediated through the Tie2 Signalling Pathway in Rheumatoid Arthritis
por: Saber, Tajvur, et al.
Publicado: (2011)

Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
por: Moran, Ellen M, et al.
Publicado: (2009)

Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder
por: Balogh, Emese, et al.
Publicado: (2013)

Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2
por: Gao, Wei, et al.
Publicado: (2013)

IL-17A Expression Is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell Infiltrates
por: Moran, Ellen M., et al.
Publicado: (2011)

Factors that influence fatigue status in patients with severe rheumatoid arthritis (RA) and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis
por: Minnock, Patricia, et al.
Publicado: (2015)

The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis
por: Turk, Matthew, et al.
Publicado: (2021)

Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis
por: Wade, Sarah M, et al.
Publicado: (2019)

Synovial tissue hypoxia and inflammation in vivo
por: Ng, C T, et al.
Publicado: (2010)

TNF polymorphisms are associated with the development of joint erosions in psoriatic arthritis
por: Kane, D, et al.
Publicado: (2003)

CD209/CD14(+) Dendritic Cells Characterization in Rheumatoid and Psoriatic Arthritis Patients: Activation, Synovial Infiltration, and Therapeutic Targeting
por: Marzaioli, Viviana, et al.
Publicado: (2022)

Psoriatic arthritis: from pathogenesis to therapy
por: FitzGerald, Oliver, et al.
Publicado: (2009)

Cardiovascular Comorbidities in Psoriatic Disease
por: Szentpetery, Agnes, et al.
Publicado: (2019)

Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
por: Pennington, Stephen R., et al.
Publicado: (2021)

Inmunohistologic analysis of synovial tissue from early and late osteoarthritic patients. A potential role for COX-2 and NF-κB1 (p50) regulation in early disease
por: Benito, MJ, et al.
Publicado: (2002)

The many faces of psoriatic arthritis: their genetic determinism
por: Winchester, Robert, et al.
Publicado: (2020)

Psoriatic arthritis synovial histopathology: commentary on the article by Kruithof and colleagues
por: FitzGerald, Oliver
Publicado: (2005)

Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures
por: Nic An Ultaigh, Sinéad, et al.
Publicado: (2011)

Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis
por: Fromm, S., et al.
Publicado: (2019)

Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors
por: Gao, W, et al.
Publicado: (2016)

Key Challenges in Rheumatic and Musculoskeletal Disease Translational Research
por: Fearon, Ursula, et al.
Publicado: (2014)

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study
por: Coates, L. C., et al.
Publicado: (2018)

Peripheral corticotropin releasing hormone signaling is mediated by Type 1alpha receptors in early human inflammatory arthritis
por: McEvoy, A, et al.
Publicado: (2001)

Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype
por: FitzGerald, Oliver, et al.
Publicado: (2015)

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis
por: Mc Ardle, Angela, et al.
Publicado: (2015)

Targeted Therapies in Psoriatic Arthritis—An Update
por: Sundanum, Sonia, et al.
Publicado: (2023)

Psoriatic arthritis: recent progress in pathophysiology and drug development
por: Veale, Douglas James
Publicado: (2013)

Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?
por: Bresnihan, Barry, et al.
Publicado: (2004)

Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue
por: O'Hara, Rosemary, et al.
Publicado: (2000)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
por: Lubrano, Ennio, et al.
Publicado: (2019)

Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis
por: Gondo, George, et al.
Publicado: (2022)

Biomarkers predictive of treatment response in psoriasis and psoriatic arthritis: a systematic review
por: Magee, Conor, et al.
Publicado: (2021)

Psoriatic Arthritis
por: Fitzgerald, Kara, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jqm0rsrik7goh5rl9h9sjkpat4